23-valent Polysaccharide Pneumococcal Vaccine in Juvenile Idiopathic Arthritis Patients Under Anti-TNF Therapy
NCT02196480
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class
Conditions
Juvenile Idiopathic Arthritis
Interventions
BIOLOGICAL:
anti-TNF
Sponsor
University of Sao Paulo